Who Exports Fludarabine from India — 64 Suppliers Behind a $2.9M Market
India's fludarabine export market is supplied by 64 active exporters who collectively shipped $2.9M across 387 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 64.3% market share, followed by AXA PARENTERALS LIMITED and UNITED BIOTECH PRIVATE LIMITED. The top 5 suppliers together control 85.6% of total export value, reflecting a concentrated market structure.
Top Fludarabine Exporters from India — Ranked by Export Value
INTAS PHARMACEUTICALS LIMITED is the leading fludarabine exporter from India, holding a 64.3% share of the $2.9M market across 387 shipments from 64 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, AXA PARENTERALS LIMITED, UNITED BIOTECH PRIVATE LIMITED, BETA DRUGS LIMITED, LIFEON PHARMACEUTICALS — collectively control 85.6% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (64.3%), AXA PARENTERALS LIMITED (14.0%), UNITED BIOTECH PRIVATE LIMITED (4.0%), BETA DRUGS LIMITED (2.1%), LIFEON PHARMACEUTICALS (1.1%).
Top Fludarabine Exporters from India
Ranked by export value · 64 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED PH.DRU.& MED.: FLUDARABINE PHOSHATE INJEPHARMA DRUGS & MEDI FLUDARABINEPHOINJ25MPHARMA DRUGS & MEDI FLUDARABINE PHO INJ | $1.9M | 9 | 64.3% |
| 2 | AXA PARENTERALS LIMITED AXADARBIN FLUDARABINE PHOSPHATE INJ 50MGFLUDARABINE PHOSPHATE FOR INJ. USP 50MGFLUDRAMED-50 PACK SIZE:1 X 1 VIAL | $404.5K | 1 | 14.0% |
| 3 | UNITED BIOTECH PRIVATE LIMITED FLUDARABINE PHOSPHATE FOR INJECTION USP50MG/VIAL | $114.2K | 8 | 4.0% |
| 4 | BETA DRUGS LIMITED AXADARBIN FLUDARABINE PHOSPHATE INJ 50MGFLUDARABINE PHOSPHATE FOR INJ. USP 50MGFLUDRAMED-50 PACK SIZE:1 X 1 VIAL | $61.8K | 5 | 2.1% |
| 5 | LIFEON PHARMACEUTICALS | $33.0K | 1 | 1.1% |
| 6 | ATLAS ENTERPRISES | $24.4K | 2 | 0.8% |
| 7 | CHANDRA BHAGAT PHARMA LIMITED PH.DRU.& MED.: FLUDARABINE PHOSHATE INJEFLUDARABINE PHOSPHATE FOR INJECTION USP | $24.3K | 2 | 0.8% |
| 8 | ELEMENTS PHARMA INC. | $21.7K | 1 | 0.8% |
| 9 | MYGENIC HEALTHCARE PRIVATE LIMITED | $19.7K | 3 | 0.7% |
| 10 | GNH INDIA PHARMACEUTICALS LIMITED | $18.5K | 1 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Fludarabine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | Warning Letter issued in | Yes, certified for f | Yes, certified | Not verified | Received FDA Warning Letter in November 2023 for CGMP violations at Matoda facil |
TransData Nexus reviewed the regulatory standing of 1 leading Fludarabine exporters from India. 0 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 1 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Fludarabine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including industry leaders like Dr. Reddy’s Laboratories and Aurobindo Pharma. This concentration of expertise and infrastructure makes Hyderabad a critical center for API manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and houses major companies such as Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The region's robust infrastructure and regulatory compliance make it a key player in the formulation segment.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a significant export gateway for pharmaceuticals. With its proximity to major ports and a well-established industrial base, this region facilitates the export of pharmaceutical products to global markets. The presence of numerous pharmaceutical companies and ancillary industries supports a thriving export ecosystem.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, is recognized as Asia's largest pharmaceutical hub. The region offers tax incentives and has attracted over 1,000 pharmaceutical manufacturing units, including major players like Cipla and Dr. Reddy's Laboratories. Baddi's strategic location and favorable policies have made it a focal point for pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: While Intas Pharmaceuticals Limited is the leading exporter of Fludarabine, accounting for 64.3% of exports, consider engaging with other suppliers such as AXA Parenterals Limited and United Biotech Private Limited to mitigate supply chain risks.
- Leverage Regional Specializations: Utilize the strengths of different pharmaceutical clusters. For instance, source APIs from Hyderabad and formulations from the Ahmedabad-Vadodara region to optimize quality and cost.
- Monitor Export Destinations: With Poland (18.0%), the Netherlands (16.0%), and Venezuela (14.9%) being top destinations for Fludarabine exports, align sourcing strategies to meet the regulatory and market demands of these regions.
- Assess Infrastructure and Logistics: Evaluate the logistical advantages of sourcing from clusters like Mumbai-Thane-Raigad, which offer superior export facilities due to their proximity to major ports.
By strategically engaging with India's diverse pharmaceutical clusters, companies can enhance their supply chain resilience and capitalize on the country's manufacturing capabilities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Fludarabine exporters from India
INTAS PHARMACEUTICALS LIMITED — FDA inspection reveals data integrity issues at Intas facility
In December 2022, a U.S. FDA inspection found that Intas's manufacturing plant in Sanand, India, was intentionally falsifying laboratory data and destroying critical quality-control records. Inspectors documented a truckload of shredded test records and multiple instances of manipulated results, raising concerns about the reliability of the potency and purity of drugs released from the facility. - IMPACT: Potential disruptions in Fludarabine exports due to regulatory scrutiny.
Impact: Potential disruptions in Fludarabine exports due to regulatory scrutiny.
Common Questions — Fludarabine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which fludarabine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 167 recorded shipments worth $1.9M. AXA PARENTERALS LIMITED (5 shipments) and UNITED BIOTECH PRIVATE LIMITED (25 shipments) are also established high-volume exporters.
Q How many fludarabine manufacturers are there in India?
India has 64 active fludarabine exporters with a combined export market of $2.9M across 387 shipments to 49 countries. The top 5 suppliers hold 85.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for fludarabine from India?
Average FOB unit price: $27.79 per unit, ranging from $0.52 to $229.36. Average shipment value: $7.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 64 verified Indian exporters of Fludarabine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 387 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 49 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
387 Verified Shipments
64 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists